Leading Oncology Sector in Talent Loss

Over the last 18 months , meaningful turnover( resignations from experienced industry valued Oncology professionals) at Teva Oncology leads the Oncology Sector.

Cephalon did an excellent job recruiting, developing, Oncology representatives. It is estimated that less than 7 representatives are left since the Treanda launch with 50 representatives leaving within the past 36 months. These experienced reps were highly regarded as they were asked to contribute to start ups and or the leading companies in the sector.

KK- Pharmacyclics
RM( mgr)- Incyte
JG-Incyte
CH-Gilead
JB-Pharmacyclics
AK-Exelixis

AA- Seattle Genetics
LC-Seattle Genetics
CC-Genentech
JC-( Mgr) Clovis
BB-(Mgr) left industry
JD- Sandoz
SM-Onyx
KP-Pharmacyclics
DA- Seattle Genetics
Doug (OK) Bayer
Kirk. ( Mich) Pharmacyclics
MK BMS
DA BMS
CH( Mgr) Taiho
Toby ( Mgr) Sandoz

This is a very short list of incredibly talented Oncology professionals who left the organization.. There are many, many more, we can't remember all of them.

Contributing Factors:
#1. Appointment of ME as ABD for West
#2. Draconian policy of holding back money from bonuses earned.
#3. BC as VP..." What is so great about an Oncology Rep"
#4. Lowest combined pay for reps in the Oncology business
#5. Infiltration of primary care into Oncology-
#6. Lack of investment into Oncology seasoned marketing and field management etc
#7. Lack of pipeline


Teva's operational mantra simply does not fit Oncology. Half of the country is run by someone who thinks the Women's health business is the same as Oncology and operates without regard to the rules ( there is no HR policy for him). The guy is dirty.

This is a place where the best people and professionals choose to leave and where mediocrity rules!

Leading Oncology Sector in Talent Loss